PMXSF (Syntara) Buyback Yield %: -6.41 (As of Jul. 01, 2026)


PMXSF Syntara Ltd PMXSF
13 GF Score
Price $0.03
! 1 Warning Sign
View Full Analysis

What is Syntara Buyback Yield %?

Syntara PMXSF 13 Buyback Yield % is -6.41 as of Jul. 01, 2026. GuruFocus rates PMXSF with a GF Score™ of 13/100. The stock has 1 warning sign investors should review. Among 292 Drug Manufacturers companies, Syntara ranks worse than 68.84% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Syntara's current buyback yield was -6.41%.

Syntara Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Syntara's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syntara Buyback Yield % Chart

Syntara Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.75 -17.87 -33.21 0.00 -28.74

Syntara Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.80 -32.53 -18.90 -21.65 -4.18

PMXSF vs ZTS, UTHR: Buyback Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Syntara's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syntara Buyback Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Syntara's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Syntara's Buyback Yield % falls into.


PMXSF
13GF Score
Syntara Ltd PMXSF
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Syntara Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Syntara's Buyback Yield for the fiscal year that ended in Jun. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-0.879 + 13.021) / 42.249948
=-28.74%

Syntara's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (-0.165 + 1.72) / 42.442374
=-3.66%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -6.41 mean?
Syntara (PMXSF) has a Buyback Yield % of -6.41 as of Jul. 01, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Syntara and its competitors. According to the industry distribution chart, Syntara ranks #201 out of 292 companies in the Drug Manufacturers industry, placing it in the top 68.8%.
Is Syntara's Buyback Yield % too high?
Syntara's current Buyback Yield % is -6.41. Based on the distribution chart, Syntara ranks #201 out of 292 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Syntara has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Syntara's Buyback Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Syntara ranks #201 out of 292 companies for Buyback Yield %. This places Syntara in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Syntara and its competitors. Syntara's current Buyback Yield % is -6.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syntara stock overvalued right now?
Syntara (PMXSF) has a current Buyback Yield % of -6.41. The current Buyback Yield % is -6.41. Syntara's overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Syntara (PMXSF), the current Buyback Yield % is -6.41 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Syntara Business Description

Other Exchanges UUDA:GermanySNT:Australia
Address 20 Rodborough Road, Unit 2, Frenchs Forest, Sydney, NSW, AUS, 2086
Syntara Ltd is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. It is targeting extracellular matrix dysfunction with its expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The company has various drug candidates in its pipeline such as SNT-5505, SNT-4728, SNT-5382, and SNT-8370 as a potential treatment for cancer, skin scarring and neuroinflammation.
13GF Score

Get the complete analysis for PMXSF

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.03
Price